ListarArtículos (Farmacología) por materia "pembrolizumab"
Mostrando ítems 1-1 de 1
-
Artículo
Impact of Frailty on Outcomes of First-Line Pembrolizumab Monotherapy in a Real-World Population with Advanced Non-Small Cell Lung Cancer
(MDPI, 2023)ICIs have been able to improve overall survival in advanced-stage lung cancer. The benefit of this therapy is limited in ...